Key facts
- Norvana’s last known valuation is $7.3M (May 2025).
- It has raised $600K; the latest was Seed Round ($600K) in May 2025.
- Notable investors include Fuel Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Norvana
- ·The full record, as it builds
Funding rounds
No funding rounds for Norvana are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Norvana
Operator of a health assistant designed to integrate nutrition, fitness, lab tests, and more to provide personalized, data-driven insights. The company's platform combines health monitoring, next-generation test results, AI-powered coaching, access to expert doctors, and personalized face scan analysis to offer users continuous, tailored healthcare solutions, enabling individuals to gain a holistic view of their well-being and improve their health through data-driven insights and actionable advice.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 6
- Website
- norvana.ai/
- Ownership
- Privately Held (backing)
Norvana doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Norvana shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Norvana in its N-PORT filings yet. We sweep new filings monthly.